Crane, George E.
February 1960
Angiology;Feb1960 Part 1, Vol. 11 Issue 1, p25
Academic Journal
1, Four tuberculous patients and one healthy control received one to four courses of Marsilid therapy, 2, Four persons exhibited hypotensive as well as hypertensive effects while one patient showed hypotension only, \n three patients the systolic blood pressure (BP) increased with each successive course of treatment. 3. One patient developed a myocardial infarction followed by death, and another patient, a cerebrovascular accident which resulted in hemiplegia. 4. Hypertension seems to be an infrequent complication in Marsilid-treated patients, but drug effects on circulatory homeostasis, other than the established hypotensive effect, may occur with some frequency.


Related Articles

  • Behind the Headlines: Can chocolate reduce stroke risk? Robinson, Stephen // GP: General Practitioner;4/9/2010, p24 

    The article cites a new study in Germany which claims that chocolate can lower a person's blood pressure (BP) and reduce their risk of cardiovascular diseases and stroke. Chocolate intake of 19,357 middle-aged people over eight years was examined by researchers in the study. They found that who...

  • 4.4. Cardiovascular Diseases.  // European Journal of Public Health;2007 Supplement 2, Vol. 17, p76 

    The article presents abstracts on cardiovascular disease topics which include blood pressure in late adolescence and occurrence of coronary heart disease and stroke in early middle age, trends in short-term acute myocardial infarction case fatality rates in Scotland, and a risk prediction model...

  • Angiotensin receptor blockers: clinical relevance and new opportunities. Volpe, Massimo // Hot Topics in Hypertension;2012, Vol. 5 Issue 14, p7 

    Effective treatment of high blood pressure (BP) is a key strategy for reducing the burden of hypertension-related cardiovascular diseases, ie, mainly stroke, myocardial infarction, heart failure, and cardiovascular death. Despite these well-established concepts, however, hypertension remains...

  • Current challenges in the clinical management of hypertension: recent studies on azilsartan. Segura, Julián; Ruilope, Luis M. // Hot Topics in Hypertension;2012, Vol. 5 Issue 14, p21 

    Arterial hypertension is the most frequent cause of death in the general population. Renin-angiotensin system suppression is a widely used therapy in hypertensive patients due to its blood pressure lowering efficacy and the capacity to prevent and regress target organ damage. Azilsartan...

  • The relationship between blood lead, blood pressure, stroke, and heart attacks in middle-aged British men Ashby, D.; Shaper, A. G.; Pocock, S. J.; Clayton, B. E. Clayton; Delves, H. T. // Environmental Health Perspectives;Jun1988, Vol. 78, p23 

    No abstract available.

  • Blood Pressure Awareness in Austria: Lessons From a 30 Years Horizon. Steiner, Sabine; Dorner, Thomas E.; George Fodor, J.; Kunze, Michael; Rieder, Anita // American Journal of Hypertension;Apr2011, Vol. 24 Issue 4, p408 

    BackgroundBlood pressure (BP) awareness is a main focus of public health efforts. In Austria, an increase of knowledge and perception regarding hypertension was seen after a nationwide educational campaign in 1978, but subsequent surveys documented only short-term impact. We report results of...

  • Blood Pressure Management: Individualized Treatment Based on Absolute Risk and the Potential for Benefit. Alderman, Michael H. // Annals of Internal Medicine;8/15/93, Vol. 119 Issue 4, p329 

    Discusses the conflict between clinical practice and epidemiologic evidence in the management of blood pressure. Association between blood pressure and the incidence of stroke and heart attack; Practical implication of continuously increasing risk associated with rising blood pressure;...

  • Aspirin prevents stroke, not Ml, in women.  // Journal of Family Practice;Jul2005, Vol. 54 Issue 7, p584 

    This article studies whether aspirin prevents cardiovascular disease in women. Aspirin reduces the risk of stroke and transient ischemic attack in women but does not reduce the risk of myocardial infarction (Ml) or cardiovascular death. The reduction in strokes over 10 years must be balanced...

  • New Information About an Old Hypertension Drug.  // HealthFacts;Dec2004, Vol. 29 Issue 12, p1 

    Presents the results of trials on the effectiveness of the hypertension drug atenolol, as of 2004. Background on the use of atenolol as a comparator drug in clinical trials; Comparison between the drug and a placebo in reducing deaths from cardiovascular disease and heart attacks; Effect of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics